DURHAM, N.C., February 8, 2017 — Premier Research announces the appointment of Nina Baluja, M.D., as Senior Medical Director for Medical Services. Dr. Baluja will perform medical and safety monitoring on clinical research projects and provide strategic guidance on protocol development, study design, regulatory filings, and study execution.
A pharmaceutical physician with more than 15 years of clinical research, medical marketing, and drug safety experience in the CRO and pharmaceutical fields, Dr. Baluja comes to Premier Research from PRA Health Sciences, where she was Senior Medical Director. Prior to that, she oversaw global regulatory consulting at PPD.
Dr. Baluja’s background in pharma includes her work as Medical Scientific Adviser at Boehringer-Ingelheim, Associate Medical Director at Wyeth Pharmaceuticals, and Trial Delivery Manager at AstraZeneca. Her areas of specialty include oncology, hemato-oncology, and rare diseases. Dr. Baluja has extensive clinical development regulatory experience, having prepared and participated in numerous scientific meetings with the FDA, EMA, and Health Canada.
She holds an MBBS degree from Pune University in India and a master’s in surgical oncology from Bombay University.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.